Conference Coverage

Antimalarials prove protective against long-term lupus damage

Publish date: November 18, 2013

 

AT THE ACR ANNUAL MEETING

Power calculations based upon the SLICC Inception Cohort Study suggest such trials could be relatively modest in size, he added.

SLICC receives financial support from GlaxoSmithKline, Bristol-Myers Squibb, and Human Genome Sciences. Dr. Bruce reported receiving research funding from GlaxoSmithKline, Bristol-Myers Squibb, Roche, and UCB.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Orthopaedic surgeons’ ‘Choosing Wisely’ list centers on osteoarthritis treatments
MDedge Surgery
Synergistic Effect of Using a Transcutaneous Electrical Joint Stimulator and an Unloading Brace in Treating Osteoarthritis of the Knee
MDedge Surgery
Isolated Vastus Lateralis Tendon Avulsion
MDedge Surgery
Web-Based Pain Management Program Useful
MDedge Surgery
THA Patient-Reported Outcomes Differ by Underlying Diagnosis
MDedge Surgery
Primary Knee Arthrodesis for Severe Crystalline Arthropathy
MDedge Surgery
Impact of Mild Chronic Hyponatremia on Falls, Fractures, Osteoporosis, and Death
MDedge Surgery
Orthopedic surgery among RA patients declining, study finds
MDedge Surgery
Knee replacement delayed by hyaluronic acid injections
MDedge Surgery
Bracing lessened patellofemoral pain in OA
MDedge Surgery